

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 4.83575621 |
| 2 | glomerular visceral epithelial cell development (GO:0072015) | 4.53272016 |
| 3 | skin morphogenesis (GO:0043589) | 4.06085733 |
| 4 | glomerular epithelial cell development (GO:0072310) | 4.01418355 |
| 5 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 4.00868647 |
| 6 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.83337820 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 3.71313640 |
| 8 | glomerular basement membrane development (GO:0032836) | 3.67695625 |
| 9 | lysine catabolic process (GO:0006554) | 3.63524131 |
| 10 | lysine metabolic process (GO:0006553) | 3.63524131 |
| 11 | 4-hydroxyproline metabolic process (GO:0019471) | 3.54005815 |
| 12 | peptidyl-proline hydroxylation (GO:0019511) | 3.48188403 |
| 13 | positive regulation of fatty acid oxidation (GO:0046321) | 3.44971421 |
| 14 | fatty acid transmembrane transport (GO:1902001) | 3.43558552 |
| 15 | regulation of cholesterol homeostasis (GO:2000188) | 3.41170381 |
| 16 | carnitine shuttle (GO:0006853) | 3.39324490 |
| 17 | hemidesmosome assembly (GO:0031581) | 3.33688917 |
| 18 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.32201567 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.30298223 |
| 20 | L-phenylalanine catabolic process (GO:0006559) | 3.30298223 |
| 21 | negative regulation of fatty acid transport (GO:2000192) | 3.30239814 |
| 22 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.29843704 |
| 23 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.27621219 |
| 24 | L-phenylalanine metabolic process (GO:0006558) | 3.20211197 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.20211197 |
| 26 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.14383611 |
| 27 | regulation of fatty acid oxidation (GO:0046320) | 3.14242376 |
| 28 | 2-oxoglutarate metabolic process (GO:0006103) | 3.12490562 |
| 29 | fatty acid beta-oxidation (GO:0006635) | 3.11669165 |
| 30 | protein retention in ER lumen (GO:0006621) | 3.09819400 |
| 31 | basement membrane organization (GO:0071711) | 3.07576644 |
| 32 | protein hydroxylation (GO:0018126) | 3.06023367 |
| 33 | * surfactant homeostasis (GO:0043129) | 3.05482718 |
| 34 | * endothelial cell chemotaxis (GO:0035767) | 3.05168445 |
| 35 | low-density lipoprotein particle clearance (GO:0034383) | 3.03878903 |
| 36 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.03829324 |
| 37 | desmosome organization (GO:0002934) | 3.02568596 |
| 38 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.02511317 |
| 39 | negative regulation of fibrinolysis (GO:0051918) | 3.01548129 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.00686866 |
| 41 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.00216492 |
| 42 | protein carboxylation (GO:0018214) | 2.97817204 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.97817204 |
| 44 | regulation of sequestering of triglyceride (GO:0010889) | 2.94904636 |
| 45 | semaphorin-plexin signaling pathway (GO:0071526) | 2.94356240 |
| 46 | fatty acid oxidation (GO:0019395) | 2.92548459 |
| 47 | histone H3-K9 demethylation (GO:0033169) | 2.92532432 |
| 48 | glucose 6-phosphate metabolic process (GO:0051156) | 2.89898559 |
| 49 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.88854628 |
| 50 | tricarboxylic acid metabolic process (GO:0072350) | 2.88806351 |
| 51 | lipid oxidation (GO:0034440) | 2.87857229 |
| 52 | cell-substrate junction assembly (GO:0007044) | 2.84842559 |
| 53 | valine metabolic process (GO:0006573) | 2.84779951 |
| 54 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.83853679 |
| 55 | atrioventricular valve morphogenesis (GO:0003181) | 2.83402452 |
| 56 | glyoxylate metabolic process (GO:0046487) | 2.79886578 |
| 57 | regulation of phospholipase A2 activity (GO:0032429) | 2.79664665 |
| 58 | positive regulation of lipid catabolic process (GO:0050996) | 2.78957384 |
| 59 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.76942396 |
| 60 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.76792984 |
| 61 | positive regulation of glycogen metabolic process (GO:0070875) | 2.76436294 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 2.76348476 |
| 63 | regulation of triglyceride catabolic process (GO:0010896) | 2.75567065 |
| 64 | short-chain fatty acid metabolic process (GO:0046459) | 2.75296281 |
| 65 | positive regulation of glycolytic process (GO:0045821) | 2.74587378 |
| 66 | plasma membrane repair (GO:0001778) | 2.71433060 |
| 67 | aromatic amino acid family catabolic process (GO:0009074) | 2.69587834 |
| 68 | fatty acid catabolic process (GO:0009062) | 2.69582490 |
| 69 | kynurenine metabolic process (GO:0070189) | 2.67326228 |
| 70 | * positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.66827741 |
| 71 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.66024535 |
| 72 | aspartate family amino acid catabolic process (GO:0009068) | 2.65356554 |
| 73 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.64704203 |
| 74 | phospholipid homeostasis (GO:0055091) | 2.64478741 |
| 75 | amino-acid betaine metabolic process (GO:0006577) | 2.64463554 |
| 76 | Golgi transport vesicle coating (GO:0048200) | 2.63231852 |
| 77 | COPI coating of Golgi vesicle (GO:0048205) | 2.63231852 |
| 78 | complement activation, alternative pathway (GO:0006957) | 2.63159449 |
| 79 | carnitine transmembrane transport (GO:1902603) | 2.63146995 |
| 80 | biotin metabolic process (GO:0006768) | 2.61723280 |
| 81 | acetyl-CoA metabolic process (GO:0006084) | 2.61518887 |
| 82 | regulation of fibrinolysis (GO:0051917) | 2.60828587 |
| 83 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.60330749 |
| 84 | high-density lipoprotein particle remodeling (GO:0034375) | 2.59908227 |
| 85 | acylglycerol homeostasis (GO:0055090) | 2.59429175 |
| 86 | triglyceride homeostasis (GO:0070328) | 2.59429175 |
| 87 | epithelial cell-cell adhesion (GO:0090136) | 2.59099271 |
| 88 | carnitine transport (GO:0015879) | 2.59036835 |
| 89 | amino-acid betaine transport (GO:0015838) | 2.59036835 |
| 90 | sarcomere organization (GO:0045214) | 2.58910389 |
| 91 | endocardial cushion morphogenesis (GO:0003203) | 2.58003454 |
| 92 | sulfur amino acid catabolic process (GO:0000098) | 2.57742591 |
| 93 | endodermal cell differentiation (GO:0035987) | 2.56079496 |
| 94 | drug catabolic process (GO:0042737) | 2.55615879 |
| 95 | Notch signaling involved in heart development (GO:0061314) | 2.55608600 |
| 96 | cardiac myofibril assembly (GO:0055003) | 2.54385579 |
| 97 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.54208541 |
| 98 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.53955962 |
| 99 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.53585842 |
| 100 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.53279845 |
| 101 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.52680546 |
| 102 | metanephric nephron epithelium development (GO:0072243) | 2.52652451 |
| 103 | regulation of protein activation cascade (GO:2000257) | 2.52583684 |
| 104 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.52364755 |
| 105 | collagen fibril organization (GO:0030199) | 2.52197334 |
| 106 | regulation of apoptotic cell clearance (GO:2000425) | 2.52148422 |
| 107 | homocysteine metabolic process (GO:0050667) | 2.52033024 |
| 108 | metanephric nephron tubule development (GO:0072234) | 2.50933168 |
| 109 | metanephric tubule development (GO:0072170) | 2.50933168 |
| 110 | macroautophagy (GO:0016236) | 2.50357202 |
| 111 | cysteine metabolic process (GO:0006534) | 2.48821222 |
| 112 | adherens junction assembly (GO:0034333) | 2.47320561 |
| 113 | regulation of extracellular matrix disassembly (GO:0010715) | 2.47223071 |
| 114 | monocarboxylic acid catabolic process (GO:0072329) | 2.47055301 |
| 115 | apoptotic cell clearance (GO:0043277) | 2.46211095 |
| 116 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.45835053 |
| 117 | carnitine metabolic process (GO:0009437) | 2.45397175 |
| 118 | protein heterotrimerization (GO:0070208) | 2.44906849 |
| 119 | * chemical homeostasis within a tissue (GO:0048875) | 2.44485749 |
| 120 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.44312682 |
| 121 | bile acid biosynthetic process (GO:0006699) | 2.44139026 |
| 122 | phosphate ion transmembrane transport (GO:0035435) | 2.44018624 |
| 123 | regulation of complement activation (GO:0030449) | 2.41924337 |
| 124 | reverse cholesterol transport (GO:0043691) | 2.41865672 |
| 125 | regulation of cholesterol storage (GO:0010885) | 2.40624291 |
| 126 | intracellular lipid transport (GO:0032365) | 2.40150100 |
| 127 | intestinal cholesterol absorption (GO:0030299) | 2.40090274 |
| 128 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.39907712 |
| 129 | cellular modified amino acid catabolic process (GO:0042219) | 2.39831835 |
| 130 | positive regulation of catenin import into nucleus (GO:0035413) | 2.39295415 |
| 131 | positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737) | 2.39215138 |
| 132 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.38894274 |
| 133 | fatty acid homeostasis (GO:0055089) | 2.38640532 |
| 134 | collagen metabolic process (GO:0032963) | 2.38452017 |
| 135 | iron ion import (GO:0097286) | 2.37970144 |
| 136 | focal adhesion assembly (GO:0048041) | 2.37803411 |
| 137 | cell-substrate adherens junction assembly (GO:0007045) | 2.37803411 |
| 138 | positive regulation of extracellular matrix organization (GO:1903055) | 2.37082160 |
| 139 | nephron tubule development (GO:0072080) | 2.36453112 |
| 140 | cell adhesion mediated by integrin (GO:0033627) | 2.36288270 |
| 141 | growth hormone receptor signaling pathway (GO:0060396) | 2.35291395 |
| 142 | regulation of extracellular matrix organization (GO:1903053) | 2.35051336 |
| 143 | cellular response to growth hormone stimulus (GO:0071378) | 2.34985067 |
| 144 | negative regulation of catenin import into nucleus (GO:0035414) | 2.34816256 |
| 145 | positive regulation of osteoblast proliferation (GO:0033690) | 2.34660224 |
| 146 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.34567446 |
| 147 | collagen catabolic process (GO:0030574) | 2.34375116 |
| 148 | urea cycle (GO:0000050) | 2.33853942 |
| 149 | urea metabolic process (GO:0019627) | 2.33853942 |
| 150 | regulation of triglyceride metabolic process (GO:0090207) | 2.33470167 |
| 151 | hormone catabolic process (GO:0042447) | 2.33358829 |
| 152 | negative regulation of lipase activity (GO:0060192) | 2.33038161 |
| 153 | metanephric epithelium development (GO:0072207) | 2.32656546 |
| 154 | cellular ketone body metabolic process (GO:0046950) | 2.32038872 |
| 155 | protein-lipid complex remodeling (GO:0034368) | 2.31508287 |
| 156 | macromolecular complex remodeling (GO:0034367) | 2.31508287 |
| 157 | plasma lipoprotein particle remodeling (GO:0034369) | 2.31508287 |
| 158 | cochlea morphogenesis (GO:0090103) | 2.29515692 |
| 159 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.29383656 |
| 160 | * regulation of p38MAPK cascade (GO:1900744) | 2.27893089 |
| 161 | protein localization to endosome (GO:0036010) | 2.25316630 |
| 162 | import into cell (GO:0098657) | 2.25233417 |
| 163 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.24363009 |
| 164 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.23975098 |
| 165 | * cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.21916354 |
| 166 | extracellular matrix disassembly (GO:0022617) | 2.21565855 |
| 167 | cell volume homeostasis (GO:0006884) | 2.20321604 |
| 168 | * positive regulation of p38MAPK cascade (GO:1900745) | 2.20072108 |
| 169 | multicellular organismal catabolic process (GO:0044243) | 2.19414905 |
| 170 | heart valve formation (GO:0003188) | 2.19048220 |
| 171 | endothelial cell morphogenesis (GO:0001886) | 2.18386182 |
| 172 | endocytic recycling (GO:0032456) | 2.18331124 |
| 173 | fructose metabolic process (GO:0006000) | 2.18111370 |
| 174 | multicellular organismal metabolic process (GO:0044236) | 2.17678861 |
| 175 | response to epidermal growth factor (GO:0070849) | 2.17652850 |
| 176 | metanephric mesenchyme development (GO:0072075) | 2.17223940 |
| 177 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.16513540 |
| 178 | myelin maintenance (GO:0043217) | 2.16504063 |
| 179 | mesenchyme morphogenesis (GO:0072132) | 2.14050025 |
| 180 | cellular response to prostaglandin stimulus (GO:0071379) | 2.13463621 |
| 181 | regulation of catenin import into nucleus (GO:0035412) | 2.12209955 |
| 182 | heart valve morphogenesis (GO:0003179) | 2.11092411 |
| 183 | regulation of early endosome to late endosome transport (GO:2000641) | 2.10688168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.41774847 |
| 2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.57132840 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.02903941 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.57472276 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.56026261 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.04508037 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.93637837 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.65329932 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.57889266 |
| 10 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.40496078 |
| 11 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.36716154 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.35041868 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.05792045 |
| 14 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.96037229 |
| 15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.95716796 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.95067229 |
| 17 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85598198 |
| 18 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.83214207 |
| 19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.77987687 |
| 20 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.76255971 |
| 21 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.76255971 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.73058677 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.67037884 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66837879 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.63848696 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58538538 |
| 27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56872437 |
| 28 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53569548 |
| 29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.52761940 |
| 30 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.49220753 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47734530 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40802497 |
| 33 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.40707496 |
| 34 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.39774164 |
| 35 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.37221450 |
| 36 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37145502 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37104974 |
| 38 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34750056 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34310961 |
| 40 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32051577 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31805814 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31793359 |
| 43 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.29728702 |
| 44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.27084940 |
| 45 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24243054 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23710223 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.23623370 |
| 48 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23419485 |
| 49 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22779630 |
| 50 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.22289293 |
| 51 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.22289293 |
| 52 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.22005286 |
| 53 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.21230813 |
| 54 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19820853 |
| 55 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.19086673 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18320113 |
| 57 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.18201129 |
| 58 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.18201129 |
| 59 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17069719 |
| 60 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.16524723 |
| 61 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.15942338 |
| 62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14623734 |
| 63 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14607905 |
| 64 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.14423686 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13203797 |
| 66 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12800044 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.12188592 |
| 68 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12094597 |
| 69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11336606 |
| 70 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09489692 |
| 71 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09220190 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08750696 |
| 73 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.08333118 |
| 74 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08066140 |
| 75 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07884803 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07382366 |
| 77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06735390 |
| 78 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06090848 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04995494 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04704646 |
| 81 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03836976 |
| 82 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.03434990 |
| 83 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03305639 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02311039 |
| 85 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02298146 |
| 86 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02100213 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99182101 |
| 88 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99104814 |
| 89 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99042590 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98813529 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98509628 |
| 92 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97651548 |
| 93 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96375726 |
| 94 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.95908555 |
| 95 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95639314 |
| 96 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.95357373 |
| 97 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94292076 |
| 98 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93347357 |
| 99 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93347357 |
| 100 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93053396 |
| 101 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.91960650 |
| 102 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91567609 |
| 103 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89806985 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87706066 |
| 105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87060846 |
| 106 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.86119082 |
| 107 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.85670886 |
| 108 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.85564327 |
| 109 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.85006676 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84328060 |
| 111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83276404 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83013024 |
| 113 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.82079247 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81904860 |
| 115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81294090 |
| 116 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80596582 |
| 117 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.80187470 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79661433 |
| 119 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79386597 |
| 120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78201615 |
| 121 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.77671039 |
| 122 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.77306374 |
| 123 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.77226360 |
| 124 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77203418 |
| 125 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.76114131 |
| 126 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.76050780 |
| 127 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.75900707 |
| 128 | TP53_16413492_ChIP-PET_HCT116_Human | 0.75860017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.18915559 |
| 2 | MP0005360_urolithiasis | 3.32266430 |
| 3 | MP0005365_abnormal_bile_salt | 3.24637635 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.12818044 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 2.91825135 |
| 6 | MP0003252_abnormal_bile_duct | 2.69017645 |
| 7 | MP0009379_abnormal_foot_pigmentation | 2.53640180 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.52324746 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.52165625 |
| 10 | MP0005076_abnormal_cell_differentiation | 2.46471204 |
| 11 | MP0004130_abnormal_muscle_cell | 2.43520377 |
| 12 | * MP0004084_abnormal_cardiac_muscle | 2.27198735 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.23207445 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.16631783 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.14803893 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.14643435 |
| 17 | MP0000579_abnormal_nail_morphology | 2.12998633 |
| 18 | MP0005409_darkened_coat_color | 2.10874523 |
| 19 | MP0003123_paternal_imprinting | 2.06732651 |
| 20 | MP0005670_abnormal_white_adipose | 2.01132168 |
| 21 | MP0003195_calcinosis | 1.95319395 |
| 22 | MP0005503_abnormal_tendon_morphology | 1.93240452 |
| 23 | MP0005666_abnormal_adipose_tissue | 1.92184457 |
| 24 | MP0004272_abnormal_basement_membrane | 1.89814143 |
| 25 | MP0004858_abnormal_nervous_system | 1.89590334 |
| 26 | MP0000751_myopathy | 1.85398446 |
| 27 | MP0002060_abnormal_skin_morphology | 1.84162353 |
| 28 | MP0004043_abnormal_pH_regulation | 1.82252730 |
| 29 | MP0005332_abnormal_amino_acid | 1.80835050 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.80320382 |
| 31 | MP0005083_abnormal_biliary_tract | 1.80314840 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.78028070 |
| 33 | MP0009840_abnormal_foam_cell | 1.77999407 |
| 34 | * MP0004036_abnormal_muscle_relaxation | 1.76085731 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.72803402 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.72450255 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.72199111 |
| 38 | MP0005023_abnormal_wound_healing | 1.68263220 |
| 39 | MP0003283_abnormal_digestive_organ | 1.68155623 |
| 40 | MP0003646_muscle_fatigue | 1.66399727 |
| 41 | MP0002118_abnormal_lipid_homeostasis | 1.62652913 |
| 42 | MP0000762_abnormal_tongue_morphology | 1.62029368 |
| 43 | MP0006138_congestive_heart_failure | 1.61169909 |
| 44 | MP0005330_cardiomyopathy | 1.59325477 |
| 45 | MP0004215_abnormal_myocardial_fiber | 1.57655758 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.56246672 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.54910640 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.53348902 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.52243258 |
| 50 | * MP0004087_abnormal_muscle_fiber | 1.48829838 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.47056001 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.46915269 |
| 53 | MP0001849_ear_inflammation | 1.46560345 |
| 54 | MP0001666_abnormal_nutrient_absorption | 1.46451502 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.44023947 |
| 56 | MP0000383_abnormal_hair_follicle | 1.42314693 |
| 57 | MP0010678_abnormal_skin_adnexa | 1.40523155 |
| 58 | * MP0010630_abnormal_cardiac_muscle | 1.37147556 |
| 59 | * MP0002972_abnormal_cardiac_muscle | 1.35063777 |
| 60 | MP0000534_abnormal_ureter_morphology | 1.34793921 |
| 61 | MP0000003_abnormal_adipose_tissue | 1.34635598 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.33288336 |
| 63 | MP0005623_abnormal_meninges_morphology | 1.32318225 |
| 64 | MP0000609_abnormal_liver_physiology | 1.31027041 |
| 65 | * MP0005385_cardiovascular_system_phenoty | 1.29731730 |
| 66 | * MP0001544_abnormal_cardiovascular_syste | 1.29731730 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.27855185 |
| 68 | MP0003115_abnormal_respiratory_system | 1.27189196 |
| 69 | MP0004782_abnormal_surfactant_physiolog | 1.26730806 |
| 70 | MP0003942_abnormal_urinary_system | 1.26063554 |
| 71 | MP0000733_abnormal_muscle_development | 1.25432686 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 1.24790787 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 1.24057566 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 1.23718231 |
| 75 | MP0000467_abnormal_esophagus_morphology | 1.21788638 |
| 76 | * MP0005620_abnormal_muscle_contractility | 1.20600848 |
| 77 | MP0000749_muscle_degeneration | 1.20472648 |
| 78 | MP0000750_abnormal_muscle_regeneration | 1.19606823 |
| 79 | MP0002971_abnormal_brown_adipose | 1.18289888 |
| 80 | MP0002896_abnormal_bone_mineralization | 1.15935567 |
| 81 | MP0003329_amyloid_beta_deposits | 1.15669393 |
| 82 | MP0001502_abnormal_circadian_rhythm | 1.15117329 |
| 83 | * MP0008775_abnormal_heart_ventricle | 1.15011064 |
| 84 | MP0000230_abnormal_systemic_arterial | 1.14144867 |
| 85 | MP0009384_cardiac_valve_regurgitation | 1.13906262 |
| 86 | MP0000537_abnormal_urethra_morphology | 1.12958403 |
| 87 | MP0003045_fibrosis | 1.12724346 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 1.11582694 |
| 89 | MP0005451_abnormal_body_composition | 1.10440301 |
| 90 | MP0003279_aneurysm | 1.09771868 |
| 91 | MP0001944_abnormal_pancreas_morphology | 1.09695922 |
| 92 | MP0001756_abnormal_urination | 1.07658338 |
| 93 | MP0001958_emphysema | 1.07234695 |
| 94 | MP0002249_abnormal_larynx_morphology | 1.06792818 |
| 95 | * MP0002269_muscular_atrophy | 1.03604489 |
| 96 | MP0000566_synostosis | 1.03318131 |
| 97 | MP0003868_abnormal_feces_composition | 1.01812570 |
| 98 | MP0005275_abnormal_skin_tensile | 1.00690211 |
| 99 | MP0001661_extended_life_span | 1.00158024 |
| 100 | MP0004233_abnormal_muscle_weight | 1.00027739 |
| 101 | MP0002234_abnormal_pharynx_morphology | 0.98060641 |
| 102 | MP0004510_myositis | 0.95463477 |
| 103 | MP0005058_abnormal_lysosome_morphology | 0.94252759 |
| 104 | MP0003806_abnormal_nucleotide_metabolis | 0.92969053 |
| 105 | MP0005334_abnormal_fat_pad | 0.92956632 |
| 106 | MP0002168_other_aberrant_phenotype | 0.92000494 |
| 107 | MP0005508_abnormal_skeleton_morphology | 0.91807219 |
| 108 | MP0005187_abnormal_penis_morphology | 0.90704287 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.90612646 |
| 110 | MP0002697_abnormal_eye_size | 0.90332287 |
| 111 | * MP0001879_abnormal_lymphatic_vessel | 0.90070079 |
| 112 | MP0004484_altered_response_of | 0.89097533 |
| 113 | MP0003385_abnormal_body_wall | 0.88964742 |
| 114 | MP0000462_abnormal_digestive_system | 0.87635189 |
| 115 | MP0005197_abnormal_uvea_morphology | 0.86965821 |
| 116 | MP0002089_abnormal_postnatal_growth/wei | 0.86684226 |
| 117 | MP0001915_intracranial_hemorrhage | 0.86083592 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.86036787 |
| 119 | MP0000759_abnormal_skeletal_muscle | 0.85063847 |
| 120 | * MP0004085_abnormal_heartbeat | 0.84699930 |
| 121 | MP0003122_maternal_imprinting | 0.84500531 |
| 122 | * MP0001614_abnormal_blood_vessel | 0.84205687 |
| 123 | * MP0002925_abnormal_cardiovascular_devel | 0.84184866 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83644794 |
| 125 | MP0005220_abnormal_exocrine_pancreas | 0.83131950 |
| 126 | MP0002822_catalepsy | 0.83058888 |
| 127 | MP0003828_pulmonary_edema | 0.82921329 |
| 128 | MP0001299_abnormal_eye_distance/ | 0.82225056 |
| 129 | * MP0002128_abnormal_blood_circulation | 0.81328031 |
| 130 | MP0002693_abnormal_pancreas_physiology | 0.81306147 |
| 131 | MP0010234_abnormal_vibrissa_follicle | 0.79146695 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.77260471 |
| 133 | * MP0003634_abnormal_glial_cell | 0.76980625 |
| 134 | * MP0002106_abnormal_muscle_physiology | 0.75127251 |
| 135 | MP0002928_abnormal_bile_duct | 0.74855634 |
| 136 | * MP0000678_abnormal_parathyroid_gland | 0.73578642 |
| 137 | MP0004019_abnormal_vitamin_homeostasis | 0.72418021 |
| 138 | MP0000767_abnormal_smooth_muscle | 0.72320315 |
| 139 | MP0002108_abnormal_muscle_morphology | 0.71696315 |
| 140 | * MP0000747_muscle_weakness | 0.71609885 |
| 141 | MP0005595_abnormal_vascular_smooth | 0.69617479 |
| 142 | MP0004859_abnormal_synaptic_plasticity | 0.68913344 |
| 143 | MP0005164_abnormal_response_to | 0.68553482 |
| 144 | * MP0003935_abnormal_craniofacial_develop | 0.68340182 |
| 145 | MP0003953_abnormal_hormone_level | 0.67833327 |
| 146 | * MP0005369_muscle_phenotype | 0.67798689 |
| 147 | * MP0000266_abnormal_heart_morphology | 0.67565172 |
| 148 | MP0002098_abnormal_vibrissa_morphology | 0.67371419 |
| 149 | MP0005165_increased_susceptibility_to | 0.67370663 |
| 150 | MP0003091_abnormal_cell_migration | 0.66420454 |
| 151 | MP0005535_abnormal_body_temperature | 0.66271747 |
| 152 | MP0003690_abnormal_glial_cell | 0.65606209 |
| 153 | MP0003879_abnormal_hair_cell | 0.64272289 |
| 154 | MP0001177_atelectasis | 0.63958074 |
| 155 | MP0002092_abnormal_eye_morphology | 0.61783342 |
| 156 | * MP0002116_abnormal_craniofacial_bone | 0.61292930 |
| 157 | MP0010771_integument_phenotype | 0.61089968 |
| 158 | * MP0000432_abnormal_head_morphology | 0.60616383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.99786094 |
| 2 | Hypoglycemic coma (HP:0001325) | 4.49200268 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.21369007 |
| 4 | Ketoacidosis (HP:0001993) | 4.06282099 |
| 5 | Premature rupture of membranes (HP:0001788) | 3.98434009 |
| 6 | Atrophic scars (HP:0001075) | 3.74321630 |
| 7 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.70012457 |
| 8 | Neonatal short-limb short stature (HP:0008921) | 3.55276189 |
| 9 | Ketosis (HP:0001946) | 3.50440236 |
| 10 | Arterial tortuosity (HP:0005116) | 3.46409753 |
| 11 | Xanthomatosis (HP:0000991) | 3.44596717 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 3.34778533 |
| 13 | Vascular tortuosity (HP:0004948) | 3.28649261 |
| 14 | Myoglobinuria (HP:0002913) | 3.26846890 |
| 15 | Hypoglycemic seizures (HP:0002173) | 3.20539636 |
| 16 | Sudden death (HP:0001699) | 3.17316068 |
| 17 | Intrahepatic cholestasis (HP:0001406) | 3.17150556 |
| 18 | Focal segmental glomerulosclerosis (HP:0000097) | 3.15835970 |
| 19 | Hyperglycemia (HP:0003074) | 2.97933622 |
| 20 | Bladder diverticulum (HP:0000015) | 2.95575470 |
| 21 | Shallow orbits (HP:0000586) | 2.86371804 |
| 22 | Aortic dissection (HP:0002647) | 2.81437268 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.81253115 |
| 24 | Exercise-induced muscle cramps (HP:0003710) | 2.81195833 |
| 25 | Hyperacusis (HP:0010780) | 2.77906905 |
| 26 | Lymphangioma (HP:0100764) | 2.76556625 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 2.74893672 |
| 28 | Polycythemia (HP:0001901) | 2.74570338 |
| 29 | Mesangial abnormality (HP:0001966) | 2.73074465 |
| 30 | Nuclear cataract (HP:0100018) | 2.72111507 |
| 31 | Skin nodule (HP:0200036) | 2.71248665 |
| 32 | Hyporeflexia of lower limbs (HP:0002600) | 2.70508731 |
| 33 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.70318952 |
| 34 | Vertebral arch anomaly (HP:0008438) | 2.69457632 |
| 35 | Ventricular tachycardia (HP:0004756) | 2.68877863 |
| 36 | Hyperglycinuria (HP:0003108) | 2.68825392 |
| 37 | Glomerulosclerosis (HP:0000096) | 2.64697487 |
| 38 | Broad metatarsal (HP:0001783) | 2.61569236 |
| 39 | Hyperlipoproteinemia (HP:0010980) | 2.61218163 |
| 40 | Late onset (HP:0003584) | 2.59641099 |
| 41 | Obstructive sleep apnea (HP:0002870) | 2.59501668 |
| 42 | Fragile skin (HP:0001030) | 2.57752057 |
| 43 | Increased connective tissue (HP:0009025) | 2.56243266 |
| 44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.53746739 |
| 45 | Soft skin (HP:0000977) | 2.52193847 |
| 46 | Wormian bones (HP:0002645) | 2.51600127 |
| 47 | Biconcave vertebral bodies (HP:0004586) | 2.50549650 |
| 48 | Muscle fiber splitting (HP:0003555) | 2.48168777 |
| 49 | Epidermoid cyst (HP:0200040) | 2.48048361 |
| 50 | Exercise-induced myalgia (HP:0003738) | 2.47989223 |
| 51 | Abnormality of dentin (HP:0010299) | 2.47393996 |
| 52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.46962701 |
| 53 | Asymmetric septal hypertrophy (HP:0001670) | 2.46828450 |
| 54 | Hyperammonemia (HP:0001987) | 2.45875449 |
| 55 | Complement deficiency (HP:0004431) | 2.44553545 |
| 56 | Gout (HP:0001997) | 2.44458998 |
| 57 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.40114411 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.38686077 |
| 59 | Aneurysm (HP:0002617) | 2.38575183 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.35831711 |
| 61 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.34861935 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.34861935 |
| 63 | Difficulty running (HP:0009046) | 2.34509937 |
| 64 | Abnormality of proline metabolism (HP:0010907) | 2.31970549 |
| 65 | Hydroxyprolinuria (HP:0003080) | 2.31970549 |
| 66 | Mitral valve prolapse (HP:0001634) | 2.31467312 |
| 67 | Nephritis (HP:0000123) | 2.31051345 |
| 68 | Symptomatic seizures (HP:0011145) | 2.28849377 |
| 69 | Hyperkalemia (HP:0002153) | 2.28150091 |
| 70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.28002647 |
| 71 | Bronchomalacia (HP:0002780) | 2.27068661 |
| 72 | Atrioventricular block (HP:0001678) | 2.26856746 |
| 73 | Asymmetry of the thorax (HP:0001555) | 2.24670676 |
| 74 | Cerebral aneurysm (HP:0004944) | 2.24012986 |
| 75 | Visceral angiomatosis (HP:0100761) | 2.23901322 |
| 76 | Esophageal varix (HP:0002040) | 2.22843959 |
| 77 | Abnormality of purine metabolism (HP:0004352) | 2.22247483 |
| 78 | Hyperextensible skin (HP:0000974) | 2.22149975 |
| 79 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.21359677 |
| 80 | Mitral regurgitation (HP:0001653) | 2.20304922 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.20063075 |
| 82 | Myocardial infarction (HP:0001658) | 2.19573051 |
| 83 | Turricephaly (HP:0000262) | 2.18037316 |
| 84 | Atrial fibrillation (HP:0005110) | 2.17825279 |
| 85 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.16553335 |
| 86 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.15600955 |
| 87 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.15600955 |
| 88 | Syncope (HP:0001279) | 2.15290370 |
| 89 | Broad face (HP:0000283) | 2.15235629 |
| 90 | Aortic aneurysm (HP:0004942) | 2.12395833 |
| 91 | Mild short stature (HP:0003502) | 2.12189302 |
| 92 | Glomerulonephritis (HP:0000099) | 2.11756839 |
| 93 | Ulnar bowing (HP:0003031) | 2.11615124 |
| 94 | Bundle branch block (HP:0011710) | 2.11575918 |
| 95 | Hypoplastic ischia (HP:0003175) | 2.11400333 |
| 96 | Hypolipoproteinemia (HP:0010981) | 2.10999715 |
| 97 | Abnormality of complement system (HP:0005339) | 2.10858361 |
| 98 | Type 1 muscle fiber predominance (HP:0003803) | 2.10617600 |
| 99 | Hemangiomatosis (HP:0007461) | 2.09428490 |
| 100 | Advanced eruption of teeth (HP:0006288) | 2.06580504 |
| 101 | Blue sclerae (HP:0000592) | 2.03403059 |
| 102 | Ankyloglossia (HP:0010296) | 2.03217477 |
| 103 | Subaortic stenosis (HP:0001682) | 2.02520662 |
| 104 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.02520662 |
| 105 | Increased variability in muscle fiber diameter (HP:0003557) | 2.02031177 |
| 106 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.01360562 |
| 107 | Tibial bowing (HP:0002982) | 2.01258962 |
| 108 | Abnormality of the ischium (HP:0003174) | 2.00357842 |
| 109 | Lipoatrophy (HP:0100578) | 1.99629712 |
| 110 | Abnormal gallbladder physiology (HP:0012438) | 1.99407366 |
| 111 | Cholecystitis (HP:0001082) | 1.99407366 |
| 112 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.99203613 |
| 113 | Potter facies (HP:0002009) | 1.99129385 |
| 114 | Facial shape deformation (HP:0011334) | 1.99129385 |
| 115 | Hyperglycinemia (HP:0002154) | 1.98418919 |
| 116 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.97825801 |
| 117 | Primary atrial arrhythmia (HP:0001692) | 1.97766996 |
| 118 | Hematochezia (HP:0002573) | 1.97652856 |
| 119 | Spinal rigidity (HP:0003306) | 1.97617787 |
| 120 | Natal tooth (HP:0000695) | 1.96793866 |
| 121 | Hyperactive renin-angiotensin system (HP:0000841) | 1.96790544 |
| 122 | Back pain (HP:0003418) | 1.96013716 |
| 123 | Large for gestational age (HP:0001520) | 1.95012400 |
| 124 | Heart block (HP:0012722) | 1.94572398 |
| 125 | Insulin resistance (HP:0000855) | 1.94097325 |
| 126 | Calf muscle hypertrophy (HP:0008981) | 1.93705396 |
| 127 | Overgrowth (HP:0001548) | 1.93666120 |
| 128 | Cervical subluxation (HP:0003308) | 1.93011324 |
| 129 | Aortic regurgitation (HP:0001659) | 1.92757143 |
| 130 | Wide anterior fontanel (HP:0000260) | 1.92085181 |
| 131 | Renovascular hypertension (HP:0100817) | 1.91082986 |
| 132 | Vertebral compression fractures (HP:0002953) | 1.90818606 |
| 133 | Enlarged penis (HP:0000040) | 1.90405612 |
| 134 | Abnormal atrioventricular conduction (HP:0005150) | 1.89587432 |
| 135 | Rhabdomyolysis (HP:0003201) | 1.89526475 |
| 136 | Prolonged QT interval (HP:0001657) | 1.88876063 |
| 137 | Hammertoe (HP:0001765) | 1.88420388 |
| 138 | Morphological abnormality of the middle ear (HP:0008609) | 1.87363318 |
| 139 | Ventricular arrhythmia (HP:0004308) | 1.87170871 |
| 140 | Bowel diverticulosis (HP:0005222) | 1.85763773 |
| 141 | Prolonged partial thromboplastin time (HP:0003645) | 1.85730101 |
| 142 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.85561071 |
| 143 | Genu recurvatum (HP:0002816) | 1.85001106 |
| 144 | Insomnia (HP:0100785) | 1.84744427 |
| 145 | Renal duplication (HP:0000075) | 1.84694396 |
| 146 | Palpitations (HP:0001962) | 1.84678319 |
| 147 | Cerebral inclusion bodies (HP:0100314) | 1.84651007 |
| 148 | Long toe (HP:0010511) | 1.83732038 |
| 149 | Supraventricular arrhythmia (HP:0005115) | 1.82549739 |
| 150 | Thin ribs (HP:0000883) | 1.82148859 |
| 151 | Flat acetabular roof (HP:0003180) | 1.81331220 |
| 152 | Mitral stenosis (HP:0001718) | 1.80810860 |
| 153 | Dilated cardiomyopathy (HP:0001644) | 1.80006517 |
| 154 | Flat cornea (HP:0007720) | 1.79308777 |
| 155 | Hemorrhage of the eye (HP:0011885) | 1.79222899 |
| 156 | Metaphyseal cupping (HP:0003021) | 1.79028018 |
| 157 | Breech presentation (HP:0001623) | 1.78820202 |
| 158 | Supraventricular tachycardia (HP:0004755) | 1.78461114 |
| 159 | Peritonitis (HP:0002586) | 1.78074632 |
| 160 | Generalized aminoaciduria (HP:0002909) | 1.78004746 |
| 161 | Abnormality of the calf musculature (HP:0001430) | 1.77201107 |
| 162 | Axonal loss (HP:0003447) | 1.76451763 |
| 163 | Disproportionate tall stature (HP:0001519) | 1.74252038 |
| 164 | Venous abnormality (HP:0002624) | 1.73080358 |
| 165 | Distal lower limb amyotrophy (HP:0008944) | 1.72713859 |
| 166 | Abnormality of the acetabulum (HP:0003170) | 1.72324251 |
| 167 | Hypoplasia of the iris (HP:0007676) | 1.71836052 |
| 168 | Nonimmune hydrops fetalis (HP:0001790) | 1.68603418 |
| 169 | Joint laxity (HP:0001388) | 1.68110799 |
| 170 | Pterygium (HP:0001059) | 1.67757757 |
| 171 | Distal upper limb amyotrophy (HP:0007149) | 1.67621473 |
| 172 | Upper limb amyotrophy (HP:0009129) | 1.67621473 |
| 173 | Aplasia involving bones of the extremities (HP:0009825) | 1.66537756 |
| 174 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.66537756 |
| 175 | Aplasia of the phalanges of the hand (HP:0009802) | 1.66537756 |
| 176 | Macroorchidism (HP:0000053) | 1.66496296 |
| 177 | Venous insufficiency (HP:0005293) | 1.66380665 |
| 178 | Thin bony cortex (HP:0002753) | 1.65415109 |
| 179 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.64005983 |
| 180 | Onion bulb formation (HP:0003383) | 1.63559109 |
| 181 | Abnormality of the calcaneus (HP:0008364) | 1.63460198 |
| 182 | Cupped ribs (HP:0000887) | 1.62753179 |
| 183 | Abnormal delivery (HP:0001787) | 1.62366193 |
| 184 | Dilatation of the ascending aorta (HP:0005111) | 1.61523663 |
| 185 | Osteoarthritis (HP:0002758) | 1.59942881 |
| 186 | Elfin facies (HP:0004428) | 1.59423320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.45302207 |
| 2 | PKN2 | 3.35942774 |
| 3 | SIK1 | 3.12365464 |
| 4 | INSRR | 2.93878979 |
| 5 | ERN1 | 2.91837875 |
| 6 | TTN | 2.46616987 |
| 7 | CDK12 | 2.43707963 |
| 8 | EEF2K | 2.33666401 |
| 9 | LATS2 | 2.29122456 |
| 10 | PDGFRA | 2.26692100 |
| 11 | TAOK3 | 2.24165472 |
| 12 | LATS1 | 2.22956247 |
| 13 | RIPK1 | 2.14905973 |
| 14 | WNK4 | 2.04844043 |
| 15 | TIE1 | 2.04432194 |
| 16 | BCKDK | 2.04208021 |
| 17 | FGFR4 | 2.00101683 |
| 18 | PTK6 | 1.87912154 |
| 19 | MOS | 1.57377514 |
| 20 | EPHB1 | 1.56008041 |
| 21 | FLT3 | 1.54025206 |
| 22 | EPHB2 | 1.53397581 |
| 23 | CAMK1D | 1.50728140 |
| 24 | CAMK1G | 1.46709819 |
| 25 | PHKG1 | 1.36126988 |
| 26 | PHKG2 | 1.36126988 |
| 27 | DMPK | 1.34460462 |
| 28 | MAP3K13 | 1.31441208 |
| 29 | FRK | 1.30334197 |
| 30 | LMTK2 | 1.30161722 |
| 31 | FGFR2 | 1.29241418 |
| 32 | SIK2 | 1.29184796 |
| 33 | AKT3 | 1.26375607 |
| 34 | TYRO3 | 1.25450354 |
| 35 | TGFBR2 | 1.22745019 |
| 36 | MYLK | 1.22667322 |
| 37 | EPHA3 | 1.22521629 |
| 38 | PRKD3 | 1.19298743 |
| 39 | PTK2 | 1.18570157 |
| 40 | OBSCN | 1.17809023 |
| 41 | MAP3K7 | 1.11840908 |
| 42 | PAK3 | 1.11285034 |
| 43 | RET | 1.09812849 |
| 44 | PIK3CA | 1.07144165 |
| 45 | FER | 1.06865523 |
| 46 | MAP3K2 | 1.06535136 |
| 47 | MET | 1.04393634 |
| 48 | PRKD1 | 1.04019003 |
| 49 | MST1R | 1.01164939 |
| 50 | FGFR3 | 1.00819688 |
| 51 | TNIK | 1.00427736 |
| 52 | PDK3 | 1.00044323 |
| 53 | PDK4 | 1.00044323 |
| 54 | PRKAA2 | 0.97811011 |
| 55 | BMX | 0.96573398 |
| 56 | PDGFRB | 0.94562909 |
| 57 | JAK1 | 0.92928919 |
| 58 | PRKCH | 0.92334236 |
| 59 | DDR2 | 0.92234082 |
| 60 | MAP3K6 | 0.90116024 |
| 61 | MAPK15 | 0.87502405 |
| 62 | PAK4 | 0.86397625 |
| 63 | HIPK2 | 0.85520213 |
| 64 | MAP3K1 | 0.84901889 |
| 65 | MTOR | 0.84728144 |
| 66 | EPHA2 | 0.81858806 |
| 67 | MAP3K9 | 0.81254410 |
| 68 | PRKAA1 | 0.81096224 |
| 69 | MAP3K3 | 0.77891443 |
| 70 | PRPF4B | 0.77766439 |
| 71 | MAP3K10 | 0.77471313 |
| 72 | NEK9 | 0.77385928 |
| 73 | GSK3A | 0.75301670 |
| 74 | DYRK1B | 0.73861942 |
| 75 | MARK1 | 0.73758973 |
| 76 | MAPKAPK3 | 0.73448377 |
| 77 | CDC42BPA | 0.73099378 |
| 78 | JAK2 | 0.72916041 |
| 79 | NTRK1 | 0.71726873 |
| 80 | IRAK3 | 0.71515881 |
| 81 | MAP2K3 | 0.70157440 |
| 82 | RPS6KA2 | 0.69859641 |
| 83 | FGFR1 | 0.69640542 |
| 84 | LRRK2 | 0.68065810 |
| 85 | NTRK3 | 0.67689976 |
| 86 | SGK494 | 0.66639256 |
| 87 | SGK223 | 0.66639256 |
| 88 | SGK3 | 0.66546458 |
| 89 | ROCK2 | 0.66212228 |
| 90 | PKN1 | 0.64897632 |
| 91 | ROCK1 | 0.63283803 |
| 92 | PDPK1 | 0.62769907 |
| 93 | SMG1 | 0.60807736 |
| 94 | BRD4 | 0.60611102 |
| 95 | WNK1 | 0.60210552 |
| 96 | NEK2 | 0.58895954 |
| 97 | KSR1 | 0.58777599 |
| 98 | ICK | 0.57464270 |
| 99 | NEK1 | 0.56765042 |
| 100 | PRKD2 | 0.52569561 |
| 101 | PAK2 | 0.52312816 |
| 102 | STK24 | 0.52213176 |
| 103 | PIK3CG | 0.51346508 |
| 104 | MAP2K1 | 0.51018376 |
| 105 | ERBB2 | 0.50020085 |
| 106 | KDR | 0.48180654 |
| 107 | MAPK11 | 0.47500766 |
| 108 | MAPK10 | 0.47307367 |
| 109 | KSR2 | 0.46934827 |
| 110 | PRKACG | 0.46539789 |
| 111 | ERBB4 | 0.45757248 |
| 112 | RPS6KL1 | 0.44912961 |
| 113 | RPS6KC1 | 0.44912961 |
| 114 | MAPK7 | 0.44889691 |
| 115 | STK38L | 0.44301898 |
| 116 | MAP2K6 | 0.43319592 |
| 117 | PDK2 | 0.43150642 |
| 118 | ARAF | 0.43064014 |
| 119 | NTRK2 | 0.42744799 |
| 120 | CDK6 | 0.42477414 |
| 121 | DAPK2 | 0.42048000 |
| 122 | ILK | 0.41235143 |
| 123 | IGF1R | 0.40729951 |
| 124 | STK38 | 0.40364508 |
| 125 | CAMK4 | 0.39606244 |
| 126 | CAMK2G | 0.39026097 |
| 127 | STK3 | 0.38324742 |
| 128 | TRPM7 | 0.36202774 |
| 129 | YES1 | 0.35839320 |
| 130 | MARK2 | 0.34705597 |
| 131 | CAMK2D | 0.33981523 |
| 132 | STK39 | 0.31969861 |
| 133 | MAPK12 | 0.31787081 |
| 134 | PRKCE | 0.30897203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.74765565 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.62225286 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42163983 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.39891419 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.31510440 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.30324719 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.25483025 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.24428392 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.18596697 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.18545704 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.08037830 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.05068353 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.02868439 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.94142397 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79099553 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.78165658 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.68401034 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.60731458 |
| 19 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.55413390 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.52297569 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.44696451 |
| 22 | Lysine degradation_Homo sapiens_hsa00310 | 1.42482519 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33883019 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33384528 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.32768429 |
| 26 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 1.32635219 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.32180240 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.31360199 |
| 29 | * Bladder cancer_Homo sapiens_hsa05219 | 1.29577691 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28550462 |
| 31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27448837 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.27410082 |
| 33 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.27332716 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26039613 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24017260 |
| 36 | Endometrial cancer_Homo sapiens_hsa05213 | 1.22529617 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20817909 |
| 38 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.20272369 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19120610 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.17309878 |
| 41 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.16608655 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15970529 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.15741406 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.14909772 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.14478149 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11906049 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10795642 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.10365387 |
| 49 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.09569051 |
| 50 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.07610669 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04586079 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.04561682 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.04062749 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.99070917 |
| 55 | Glioma_Homo sapiens_hsa05214 | 0.98762587 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98368482 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97681610 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97073205 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96423523 |
| 60 | * Pancreatic cancer_Homo sapiens_hsa05212 | 0.95165490 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.94930714 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94366663 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93829276 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90978721 |
| 65 | Prostate cancer_Homo sapiens_hsa05215 | 0.88476322 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86843410 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86192898 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85493804 |
| 69 | * Focal adhesion_Homo sapiens_hsa04510 | 0.84390871 |
| 70 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.84132862 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83577305 |
| 72 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82770421 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81994568 |
| 74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79870969 |
| 75 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78838791 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78000099 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77786788 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77233884 |
| 79 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.75987441 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75164019 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74961192 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74671516 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73340283 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73043564 |
| 85 | Tight junction_Homo sapiens_hsa04530 | 0.72767420 |
| 86 | Axon guidance_Homo sapiens_hsa04360 | 0.71567041 |
| 87 | Insulin secretion_Homo sapiens_hsa04911 | 0.71426902 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71400715 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70677317 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70387688 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.69809627 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69018845 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68926647 |
| 94 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68876494 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66889228 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65818723 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65519935 |
| 98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64998815 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62877648 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.62668163 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62038670 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61699460 |
| 103 | Gap junction_Homo sapiens_hsa04540 | 0.61423275 |
| 104 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59656770 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59556432 |
| 106 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.59366950 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58368532 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57678525 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56569221 |
| 110 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55771211 |
| 111 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.55606299 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53028871 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.52737323 |
| 114 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52526926 |
| 115 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51984747 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50733611 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.50071891 |
| 118 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48892630 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.48403631 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.47777139 |
| 121 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46967481 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45874135 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45697987 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45585762 |
| 125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45480170 |
| 126 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44685212 |
| 127 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44414877 |
| 128 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43607450 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42191842 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41740898 |
| 131 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40022050 |
| 132 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.37067591 |
| 133 | Renin secretion_Homo sapiens_hsa04924 | 0.35733246 |
| 134 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34798604 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34568985 |
| 136 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.33809483 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.33643651 |
| 138 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33615251 |
| 139 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33146032 |
| 140 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31222380 |
| 141 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30454805 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.30203715 |
| 143 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28657330 |
| 144 | Lysosome_Homo sapiens_hsa04142 | 0.28327773 |
| 145 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24961782 |

